Modeling of the infectious process in Galleria mellonella larvae to evaluate the antibacterial effect of cationic peptide compounds in vivo

Authors

  • Aleksandr N. Lobanov Institute of Ecology and Genetics of Microorganisms, Perm, Russia
  • Marina V. Antipeva Institute of Ecology and Genetics of Microorganisms, Perm, Russia
  • Daria V. Eroshenko Institute of Ecology and Genetics of Microorganisms, Perm, Russia
  • Tatyana V. Polyudova Institute of Ecology and Genetics of Microorganisms, Perm, Russia

DOI:

https://doi.org/10.17072/1994-9952-2026-2-169-178

Keywords:

waxworm, antibacterial activity, cationic peptides, colistin, protamine, bacterial infection

Abstract

A comparative virulence assessment of Escherichia coli ATCC 25922, E. coli M-17, Pseudomonas fluorescens ATCC 948, Bacillus subtilis ATCC 6633, Listeria innocua M-2, and Listeria welshimeri Bel-19 strains was conducted using the Galleria mellonella (greater wax moth) infection model. All tested strains were capable of causing infection, altering the general condition of the larvae (melanization, decreased motility, and cocoon formation). Furthermore, the study demonstrated that larval survival decreased with increasing infectious dose of bacteria and depended on larval weight. A comparative analysis of the antibacterial activity of cationic peptide compounds (colistin and protamine) in a model organism revealed that colistin ensures 100% survival of larvae infected with E. coli ATCC 25922. Protamine increased the survival of wax moth larvae after infection with B. subtilis ATCC 6633 and L. innocua M-2 compared to the control. Thus, G. mellonella larvae can be used as a model for inducing infection and subsequently in vivo assessing bacterial sensitivity to cationic peptides.

Author Biographies

  • Aleksandr N. Lobanov, Institute of Ecology and Genetics of Microorganisms, Perm, Russia
    engineer «IEGM UB RAS», postgraduate student PFRC UB RAS
  • Marina V. Antipeva, Institute of Ecology and Genetics of Microorganisms, Perm, Russia
    candidate of biological sciences, junior researcher «IEGM UB RAS», associate professor 
  • Daria V. Eroshenko, Institute of Ecology and Genetics of Microorganisms, Perm, Russia
    candidate of biological sciences, engineer «IEGM UB RAS»
  • Tatyana V. Polyudova, Institute of Ecology and Genetics of Microorganisms, Perm, Russia
    candidate of biological sciences, head of laboratory «IEGM UB RAS»

References

Список источников

1. Веслополова Е.Ф. Микрометод определения численности колониеобразующих микроорганиз-мов // Микробиология. 1995. Т. 64, № 2. С. 279–284.

2. Гайдерова Л.А. и др. Реализация концепции 3Rs при контроле качества биологических препара-тов: современное состояние и перспективы (обзор) // Безопасность и риск фармакотерапии. 2025. Т. 13(2). С. 229–239. DOI: 10.30895/2312-7821-2025-13-2-229-240. EDN: KAQUZG

3. Коновалова Т.В. Лабораторное содержание и разведение большой восковой огневки Galleria mellonella L. // Российский ветеринарный журнал. 2009. № 4. С. 45–47. EDN: PGQJDP

4. Осокина А.С., Колбина Л.М., Гущин А.В. Влияние кормления и условий содержания на рост ли-чинок большой восковой моли (Galleria mellonella L.) // Достижения науки и техники АПК. 2016. Т. 30, № 7. С. 88-92. EDN: WJXNYX

5. Определение чувствительности микроорганизмов к антимикробным препаратам. Российские рекомендации. Версия 2024-02 / МАКМАХ, СГМУ: Смоленск, 2024. 192 с.

6. Andrea A., Krogfelt K.A., Jenssen H. Methods and challenges of using the greater wax moth (Galleria mellonella) as a model organism in antimicrobial compound discovery // Microorganisms. 2019. Vol. 7(3). Art. ftab85. DOI: 10.3390/microorganisms7030085.

7. Asai M. et al. Galleria mellonella-intracellular bacteria pathogen infection models: the ins and outs // FEMS Microbiol. Rev. 2023. Vol. 47(2). Art. fuad011. DOI: 10.1093/femsre/fuad011. EDN: PBWDQO

8. Banville N., Browne N., Kavanagh K. Effect of nutrient deprivation on the susceptibility of Galleria mellonella larvae to infection // Virulence. 2012. Vol. 3, № 6. P. 497–503. DOI: 10.4161/viru.21972.

9. Champion O.L., Wagley S., Titball R.W. Galleria mellonella as a model host for microbiological and toxin research // Virulence. 2016 Vol. 7(7). P. 840-5. DOI: 10.1080/21505594.2016.1203486.

10. Chen R.Y., Keddie B.A. The Galleria mellonella-enteropathogenic Escherichia coli model system: characterization of pathogen virulence and insect immune responses // J. Insect Sci. 2021. Vol. 21(4). Art. 7. DOI: 10.1093/jisesa/ieab046. EDN: UYWYR

11. Dinh H. et al. Microbiology's next top model: Galleria in the molecular age // Pathog. Dis. 2021. Vol. 79(2). Art. ftab006. DOI: 10.1093/femspd/ftab006. EDN: TKXTAQ

12. Hesketh-Best P.J. et al. Galleria mellonella larvae exhibit a weight-dependent lethal median dose when infected with methicillin-resistant Staphylococcus aureus // Pathogens and disease. 2021. Vol. 79, № 2. Art. ftab003. DOI: 10.1093/femspd/ftab003. EDN: GKKTAB

13. Hoffmann J.A. Innate immunity of insects // Curr. Opin. Immunol. 1995. Vol. 7(1). P. 4–10. DOI: 10.1016/0952-7915(95)80022-0.

14. Hofkens N. et al. Microbisporicin (NAI-107) protects Galleria mellonella from infection with Neis-seria gonorrhoeae // Microbiol. Spectr. 2023. Vol. 11(6). Art. e0282523. DOI: 10.1128/spectrum.02825-23. EDN: CPQYFJ

15. Jorjão A.L. et al. From moths to caterpillars: Ideal conditions for Galleria mellonella rearing for in vivo microbiological studies // Virulence. 2018. Vol. 9. P. 383–389. DOI: 10.1080/21505594.2017.1397871.

16. Kavanagh K., Sheehan G. The use of Galleria mellonella larvae to identify novel antimicrobial agents against fungal species of medical interest // J. Fungi (Basel). 2018. Vol. 4(3). Art. 113. DOI: 10.3390/jof4030113.

17. Malmquist J.A., Rogan M.R., McGillivray S.M. Galleria mellonella as an infection model for Bacil-lus anthracis sterne // Front. Cell. Infect. Microbiol. 2019. Vol. 9. Art. 360. DOI: 10.3389/fcimb.2019.00360.

18. Mukherjee K. et al. Galleria mellonella as a model system for studying Listeria pathogenesis // Appl. Environ. Microbiol. 2010. Vol. 76(1). P. 310–317. DOI: 10.1128/AEM.01301-09. EDN: NYONEB

19. Ookubo M. et al. “Rich arginine and strong positive charge” antimicrobial protein protamine: From its action on cell membranes to inhibition of bacterial vital functions // Biochimica et Biophysica Acta (BBA)-Biomembranes. 2024. Т. 1866, № 5. Art. 184323. DOI: 10.1016/j.bbamem.2024.184323. EDN: NYWNRO

20. Piatek M., Sheehan G., Kavanagh K. Utilising Galleria mellonella larvae for studying in vivo activi-ty of conventional and novel antimicrobial agents // Pathog. Dis. 2020. Vol. 78(8). Art. ftaa059. DOI: 10.1093/femspd/ftaa059. EDN: TTMTSY

21. Serrano I. et al. The virtuous Galleria mellonella model for scientific experimentation // Antibiotics (Basel). 2023. Vol. 12(3). Art. 505. DOI: 10.3390/antibiotics12030505. EDN: ITADWL

22. Vertyporokh L., Hułas-Stasiak M., Wojda I. Host-pathogen interaction after infection of Galleria mellonella with the filamentous fungus Beauveria bassiana // Insect Sci. 2020. Vol. 27(5). P. 1079–1089. DOI: 10.1111/1744-7917.12706. EDN: ZKIICX

23. Wang G. et al. APD6: the antimicrobial peptide database is expanded to promote research and de-velopment by deploying an unprecedented information pipeline // Nucleic Acids Res. 2026. Vol. 54(D1). P. 363–374. DOI: 10.1093/nar/gkaf860.

24. White D., Sykes E.M.E., Kumar A. Galleria mellonella as an infection and antibiotic treatment mod-el for Acinetobacter baumannii // J. Vis. Exp. 2025. № 221. Art. e68625. DOI: 10.3791/68625. EDN: WCGDLI

25. World Health Organization. The WHO AWaRe (access, watch, reserve) antibiotic book. World Health Organization, 2022.

26. Zhou L. et al. Developmental changes for the hemolymph metabolome of silkworm (Bombyx mori L.) // J. Proteome Res. 2015. Vol. 14(5). P. 2331–2347. DOI: 10.1021/acs.jproteome.5b00159.

References

1. Veslopolova E.F. [Micromethod for determining the number of colony-forming microorganisms]. Mikrobiologija. V. 64, No. 2 (1995): pp. 279-284. (In Russ.).

2. Gaiderova L.A. et al. [Implementation of the 3Rs concept in quality control of biological products: current state and prospects (review)]. Bezopasnost’ i risk farmakoterapii. V. 13(2) (2025): pp. 229-239. (In Russ.).DOI: 10.30895/2312-7821-2025-13-2-229-240. EDN: KAQUZG

3. Konovalova T.V. [Laboratory maintenance and breeding of the greater wax moth Galleria mellonella L.]. Rossijskij veterinarnyj žurnal. No. 4 (2009): pp. 45-47. (In Russ.). EDN: PGQJDP

4. Osokina A.S., Kolbina L.M., Gushchin A.V. [Effect of feeding and maintenance conditions on the growth of larvae of the greater wax moth (Galleria mellonella L.)]. Dostižnija nauki i techniki APK. V. 30, No. 7 (2016): pp. 88-92. (In Russ.). EDN: WJXNYX

5. Opredelenie čuvstvitel’nosti mikroorganizmov k antimikrobnym preparatam. Rossijskie rekomendacii. Versija 2024-02 [Russian guidelines. Determination of antimicrobial susceptibility of mi-croorganisms. Version 2024-02]. MAKMAKH, SGMU: Smolensk, 2024. 192 p. (In Russ.).

6. Andrea A., Krogfelt K.A., Jenssen H. Methods and Challenges of Using the Greater Wax Moth (Gal-leria mellonella) as a Model Organism in Antimicrobial Compound Discovery. Microorganisms. V. 7(3) (2019). Art. ftab85. DOI: 10.3390/microorganisms7030085.

7. Asai M. et al. Galleria mellonella-intracellular bacteria pathogen infection models: the ins and outs. FEMS Microbiol. Rev. V. 47(2) (2023). Art. fuad011. DOI: 10.1093/femsre/fuad011. EDN: PBWDQO

8. Banville N., Browne N., Kavanagh K. Effect of nutrient deprivation on the susceptibility of Galleria mellonella larvae to infection. Virulence. V. 3, No. 6 (2012): pp. 497-503. DOI: 10.4161/viru.21972.

9. Champion O.L., Wagley S., Titball R.W. Galleria mellonella as a model host for microbiological and toxin research. Virulence. V. 7(7) (2016): pp. 840-5. DOI: 10.1080/21505594.2016.1203486.

10. Chen R.Y., Keddie B.A. The Galleria mellonella-enteropathogenic Escherichia coli model system: characterization of pathogen virulence and insect immune responses. J. Insect Sci. V. 21(4) (2021). Art. 7. DOI: 10.1093/jisesa/ieab046. EDN: UYWYR

11. Dinh H. et al. Microbiology's next top model: Galleria in the molecular age. Pathog. Dis. V. 79(2) (2021). Art. ftab006. DOI: 10.1093/femspd/ftab006. EDN: TKXTAQ

12. Hesketh-Best P.J. et al. Galleria mellonella larvae exhibit a weight-dependent lethal median dose when infected with methicillin-resistant Staphylococcus aureus. Pathogens and disease. V. 79, No. 2 (2021). Art. ftab003. DOI: 10.1093/femspd/ftab003. EDN: GKKTAB

13. Hoffmann J.A. Innate immunity of insects. Curr. Opin. Immunol. V. 7(1). (1995): pp. 4-10. DOI: 10.1016/0952-7915(95)80022-0.

14. Hofkens N. et al. Microbisporicin (NAI-107) protects Galleria mellonella from infection with Neis-seria gonorrhoeae. Microbiol. Spectr. V. 11(6) (2023). Art. e0282523. DOI: 10.1128/spectrum.02825-23. EDN: CPQYFJ

15. Jorjão A.L. et al. From moths to caterpillars: Ideal conditions for Galleria mellonella rearing for in vivo microbiological studies. Virulence. V. 9 (2018): pp. 383-389. DOI: 10.1080/21505594.2017.1397871.

16. Kavanagh K., Sheehan G. The Use of Galleria mellonella Larvae to Identify Novel Antimicrobial Agents against Fungal Species of Medical Interest. J. Fungi (Basel). V. 4(3) (2018). Art. 113. DOI: 10.3390/jof4030113.

17. Malmquist J.A., Rogan M.R., McGillivray S.M. Galleria mellonella as an Infection Model for Bacil-lus anthracis Sterne. Front. Cell. Infect. Microbiol. V. 9 (2019). Art. 360. DOI: 10.3389/fcimb.2019.00360.

18. Mukherjee K. et al. Galleria mellonella as a model system for studying Listeria pathogenesis. Appl. Environ. Microbiol. V. 76(1) (2010): pp. 310-317. DOI: 10.1128/AEM.01301-09. EDN: NYONEB

19. Ookubo M. et al. “Rich arginine and strong positive charge” antimicrobial protein protamine: From its action on cell membranes to inhibition of bacterial vital functions. Biochimica et Biophysica Acta (BBA)-Biomembranes. V. 1866. No. 5 (2024). Art. 184323. DOI: 10.1016/j.bbamem.2024.184323. EDN: NYWNRO

20. Piatek M., Sheehan G., Kavanagh K. Utilising Galleria mellonella larvae for studying in vivo activi-ty of conventional and novel antimicrobial agents. Pathog. Dis. V. 78(8) (2020). Art. ftaa059. DOI: 10.1093/femspd/ftaa059. EDN: TTMTSY

21. Serrano I. et al. The Virtuous Galleria mellonella Model for Scientific Experimentation. Antibiotics (Basel). V. 12(3) (2023). Art. 505. DOI: 10.3390/antibiotics12030505. EDN: ITADWL

22. Vertyporokh L., Hułas-Stasiak M., Wojda I. Host-pathogen interaction after infection of Galleria mellonella with the filamentous fungus Beauveria bassiana. Insect Sci. V. 27(5) (2020): pp. 1079-1089. DOI: 10.1111/1744-7917.12706. EDN: ZKIICX

23. Wang G. et al. APD6: the antimicrobial peptide database is expanded to promote research and de-velopment by deploying an unprecedented information pipeline. Nucleic Acids Res. V. 54(D1) (2026): pp. 363-374. DOI: 10.1093/nar/gkaf860.

24. White D., Sykes E.M.E., Kumar A. Galleria mellonella as an Infection and Antibiotic Treatment Model for Acinetobacter baumannii. J. Vis. Exp. No. 221 (2025). Art. e68625. DOI: 10.3791/68625. EDN: WCGDLI

25. World Health Organization. The WHO AWaRe (access, watch, reserve) antibiotic book. - World Health Organization, 2022.

26. Zhou L. et al. Developmental Changes for the Hemolymph Metabolome of Silkworm (Bombyx mori L.). J. Proteome Res. V. 14(5) (2015): pp. 2331-2347. DOI: 10.1021/acs.jproteome.5b00159.

Downloads

Published

2026-07-07

Issue

Section

Микробиология

How to Cite

Modeling of the infectious process in Galleria mellonella larvae to evaluate the antibacterial effect of cationic peptide compounds in vivo. (2026). Bulletin of Perm University. Biology, 17(2), 169-178. https://doi.org/10.17072/1994-9952-2026-2-169-178

Similar Articles

1-10 of 101

You may also start an advanced similarity search for this article.